静脈注射針市場：ゲージ別、エンドユーザー別-2025-2030年の世界予測

静脈注射針市場は、2023年に20億3,000万米ドルと評価され、2024年には21億4,000万米ドルに達すると予測され、CAGR 6.18％で成長し、2030年には30億9,000万米ドルに達すると予測されています。

静脈注射針の市場範囲には、病院、外来医療、在宅ヘルスケア、救急医療サービスなどの場面で重要な、患者の静脈に直接薬剤、栄養剤、輸液を注入するために設計された医療機器が含まれます。その必要性は、特に重症患者や慢性疾患患者への効率的なドラッグデリバリーが不可欠であることに起因しています。静脈注射針は、化学療法、脱水治療、輸血、疼痛管理などに主に使用されています。エンドユーザーはヘルスケア主体から専門クリニック、在宅医療に至るまで幅広く、慢性疾患の蔓延や高齢化に伴い需要が高まっています。

主な成長促進要因としては、安全設計針などの技術進歩、世界のヘルスケア支出の増加、発展途上地域における医療アクセスの拡大などが挙げられます。在宅ヘルスケア市場の急成長は、患者が病院外での治療を好むため、需要をさらに高める。医療インフラが拡大しつつある新興市場にこそチャンスがあります。企業は、製品の安全性を重視し、針刺し損傷を減らし、スマート技術を統合して薬剤投与をモニターすることで、技術革新を活用することができます。

厳しい規制要件と質の高いコンプライアンス遵守の必要性による課題も存在します。主に市場競争力学と償還問題による価格圧力が成長を抑制する可能性があります。さらに、COVID-19パンデミックはサプライチェーンを混乱させ、市場の安定性に一時的な影響を与えました。

技術革新の分野には、安全機構を強化した針の開発、医療廃棄物を削減するための環境に優しい素材の開発、患者の使用状況や投与効率を追跡するためのデジタル統合などが含まれます。スマート針のソリューションを開発するためにハイテク企業とのパートナーシップを促進することは、変革につながる可能性があります。さらに、先進的な針の割高な価格設定を正当化するための費用便益分析を実施することで、市場への浸透が促進される可能性があります。この競合情勢で優位に立つためには、継続的な研究開発投資が推奨されます。市場競争は依然として激しいが、患者中心のソリューションと在宅ケアのイノベーションに焦点が移るにつれて、大きな成長の可能性があります。

市場力学：急速に進化する静脈注射針市場の主要市場インサイトを公開

静脈注射針市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 医療手術および処置数の増加
  • 重篤な医療現場における静脈注射針の使用の増加
  • 在宅ヘルスケアと薬剤の自己投与の新たな動向
• 市場抑制要因
  • 原材料コストの変動と製品リコールの発生
• 市場機会
  • 点滴針関連製品の遠隔医療への統合
  • 輸液針製造の進歩
• 市場の課題
  • 針刺し損傷に関する懸念

ポーターの5つの力：静脈注射針市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：静脈注射針市場における外部からの影響の把握

外部マクロ環境要因は、静脈注射針市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析静脈注射針市場における競合情勢の把握

静脈注射針市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス静脈注射針市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、静脈注射針市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨静脈注射針市場における成功への道筋を描く

静脈注射針市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医療手術や処置の増加
    • 集中治療室での点滴針の使用増加
    • 在宅ヘルスケアと薬剤の自己投与の新たなトレンド
  • 抑制要因
    • 原材料費の変動と製品リコールの発生
  • 機会
    • 点滴針関連製品と遠隔医療の統合
    • 点滴針製造の進歩
  • 課題
    • 針刺し事故に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 静脈注射針市場ゲージ

• 18ゲージ
• 20ゲージ
• 22ゲージ

第7章 静脈注射針市場：エンドユーザー別

• 診断センター
• 病院・クリニック

第8章 南北アメリカの静脈注射針市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の静脈注射針市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの静脈注射針市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abcam Inc.
• Advin Health Care
• Argon Medical Devices, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biomedical Srl
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Group Incorporated
• Freudenberg Medical, LLC
• Medtronic PLC
• Merck KGaA
• Novo Nordisk A/S
• Olympus Corporation
• PerkinElmer, Inc.
• QIAGEN
• Shimadzu Corporation
• Siemens AG
• Smith & Nephew PLC
• Stryker Corporation
• Teleflex Incorporated.
• Thermo Fisher Scientific Inc.
• Volkmann MedizinTechnik GmbH
• Zhejiang Longde Pharmaceutical Co., Ltd.

LIST OF FIGURES

• FIGURE 1. INTRAVENOUS NEEDLES MARKET RESEARCH PROCESS
• FIGURE 2. INTRAVENOUS NEEDLES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INTRAVENOUS NEEDLES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INTRAVENOUS NEEDLES MARKET DYNAMICS
• TABLE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 18 GAUGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 20 GAUGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY 22 GAUGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 22. CANADA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 34. CHINA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 36. INDIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 71. ITALY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 79. POLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 81. QATAR INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGES, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2023

The Intravenous Needles Market was valued at USD 2.03 billion in 2023, expected to reach USD 2.14 billion in 2024, and is projected to grow at a CAGR of 6.18%, to USD 3.09 billion by 2030.

The market scope for intravenous needles encompasses medical devices designed for infusing medications, nutrients, or fluids directly into patients' veins, critical in settings such as hospitals, ambulatory care, home healthcare, and emergency medical services. Their necessity is driven by the essential requirement for efficient drug delivery, especially in critical and chronic care scenarios. Intravenous needles are predominantly used in chemotherapy, dehydration treatment, blood transfusion, and pain management. The end-users range from healthcare providers to specialized clinics and home healthcare settings, where demand is tied to the rise in chronic disease prevalence and aging populations.

Key growth-fostering factors include technological advancements like safety-engineered needles, increasing global healthcare expenditures, and expanded healthcare access in developing regions. The burgeoning home healthcare market further enhances demand, as patients prefer treatment outside hospital settings. Opportunities lie in emerging markets where healthcare infrastructure is expanding. Companies can leverage innovation by focusing on product safety, reducing needlestick injuries, and integrating smart technologies to monitor medication delivery.

Challenges persist due to stringent regulatory requirements and the need for high-quality compliance. Pricing pressures, primarily due to competitive market dynamics and reimbursement issues, may restrain growth. Moreover, the COVID-19 pandemic has disrupted supply chains, affecting market stability temporarily.

Innovation areas include developing needles with enhanced safety mechanisms, eco-friendly materials to reduce medical waste, and digital integration for tracking patient usage and dosage efficiency. Fostering partnerships with tech firms to develop smart needle solutions could be transformative. Additionally, conducting cost-benefit analyses to justify the premium pricing of advanced needles could aid market penetration. Continuous R&D investment is recommended to stay ahead in this competitive landscape. The market remains highly competitive with significant potential for growth as focus shifts towards patient-centric solutions and homecare innovations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Needles Market

The Intravenous Needles Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in number of medical surgeries and procedures
  • Growing use of IV needles in critical care settings
  • Emerging trend of home healthcare and self-administration of drugs
• Market Restraints
  • Volatility in raw material cost and incidences of product recall
• Market Opportunities
  • Integration of IV needle-related products with telemedicine
  • Advancements in IV needle manufacturing
• Market Challenges
  • Concerns associated with needlestick injuries

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Needles Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Needles Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Needles Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Needles Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Needles Market

A detailed market share analysis in the Intravenous Needles Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Needles Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Needles Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Needles Market

A strategic analysis of the Intravenous Needles Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Needles Market, highlighting leading vendors and their innovative profiles. These include Abcam Inc., Advin Health Care, Argon Medical Devices, Inc., B. Braun SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomedical Srl, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Freudenberg Medical, LLC, Medtronic PLC, Merck KGaA, Novo Nordisk A/S, Olympus Corporation, PerkinElmer, Inc., QIAGEN, Shimadzu Corporation, Siemens AG, Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated., Thermo Fisher Scientific Inc., Volkmann MedizinTechnik GmbH, and Zhejiang Longde Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Needles Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Gauges, market is studied across 18 Gauge, 20 Gauge, and 22 Gauge.
• Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in number of medical surgeries and procedures
    • 5.1.1.2. Growing use of IV needles in critical care settings
    • 5.1.1.3. Emerging trend of home healthcare and self-administration of drugs
  • 5.1.2. Restraints
    • 5.1.2.1. Volatility in raw material cost and incidences of product recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of IV needle-related products with telemedicine
    • 5.1.3.2. Advancements in IV needle manufacturing
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with needlestick injuries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Intravenous Needles Market, by Gauges

• 6.1. Introduction
• 6.2. 18 Gauge
• 6.3. 20 Gauge
• 6.4. 22 Gauge

7. Intravenous Needles Market, by End User

• 7.1. Introduction
• 7.2. Diagnostic Centers
• 7.3. Hospitals & Clinics

8. Americas Intravenous Needles Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Intravenous Needles Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Intravenous Needles Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam Inc.
• 2. Advin Health Care
• 3. Argon Medical Devices, Inc.
• 4. B. Braun SE
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. Biomedical Srl
• 8. Boston Scientific Corporation
• 9. Cardinal Health, Inc.
• 10. Cook Group Incorporated
• 11. Freudenberg Medical, LLC
• 12. Medtronic PLC
• 13. Merck KGaA
• 14. Novo Nordisk A/S
• 15. Olympus Corporation
• 16. PerkinElmer, Inc.
• 17. QIAGEN
• 18. Shimadzu Corporation
• 19. Siemens AG
• 20. Smith & Nephew PLC
• 21. Stryker Corporation
• 22. Teleflex Incorporated.
• 23. Thermo Fisher Scientific Inc.
• 24. Volkmann MedizinTechnik GmbH
• 25. Zhejiang Longde Pharmaceutical Co., Ltd.